Evidence map›Paper›PMID 36567336›Full record

ArticleBMC cardiovascular disorders2022

Diagnostic signature for heart failure with preserved ejection fraction (HFpEF): a machine learning approach using multi-modality electronic health record data.

Nazli Farajidavar, Kevin O'Gallagher, Daniel Bean, Adam Nabeebaccus, Rosita Zakeri, Daniel Bromage, Zeljko Kraljevic, James T H Teo, Richard J Dobson, Ajay M Shah

Open access · goldAbstract read
In one paragraph

Article in BMC cardiovascular disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Nazli Farajidavar *King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.
Kevin O'Gallagher *King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.
Daniel BeanKing's College London British Heart Foundation Centre of Excellence, School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.
Adam NabeebaccusKing's College London British Heart Foundation Centre of Excellence, School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.
Rosita ZakeriKing's College London British Heart Foundation Centre of Excellence, School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.
Daniel BromageKing's College London British Heart Foundation Centre of Excellence, School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.
Zeljko KraljevicDepartment of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
James T H TeoKing's College Hospital NHS Foundation Trust, London, UK.
Richard J DobsonKing's College London British Heart Foundation Centre of Excellence, School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.
Ajay M ShahKing's College London British Heart Foundation Centre of Excellence, School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK. ajay.shah@kcl.ac.uk.
King's College London · GBBritish Heart Foundation · GBKing's College Hospital NHS Foundation Trust · GB

Funding

British Heart Foundation CH/1999001/11735British Heart Foundation RE/18/2/34213Medical Research Council MR/R017751/1Medical Research Council MR/S00310X/1
6 · The paper itself

Abstract

backgroundHeart failure with preserved ejection fraction (HFpEF) is thought to be highly prevalent yet remains underdiagnosed. Evidence-based treatments are available that increase quality of life and decrease hospitalization. We sought to develop a data-driven diagnostic model to predict from electronic health records (EHR) the likelihood of HFpEF among patients with unexplained dyspnea and preserved left ventricular EF. METHODS AND

resultsThe derivation cohort comprised patients with dyspnea and echocardiography results. Structured and unstructured data were extracted using an automated informatics pipeline. Patients were retrospectively diagnosed as HFpEF (cases), non-HF (control cohort I), or HF with reduced EF (HFrEF; control cohort II). The ability of clinical parameters and investigations to discriminate cases from controls was evaluated by extreme gradient boosting. A likelihood scoring system was developed and validated in a separate test cohort. The derivation cohort included 1585 consecutive patients: 133 cases of HFpEF (9%), 194 non-HF cases (Control cohort I) and 1258 HFrEF cases (Control cohort II). Two HFpEF diagnostic signatures were derived, comprising symptoms, diagnoses and investigation results. A final prediction model was generated based on the averaged likelihood scores from these two models. In a validation cohort consisting of 269 consecutive patients [with 66 HFpEF cases (24.5%)], the diagnostic power of detecting HFpEF had an AUROC of 90% (P < 0.001) and average precision of 74%.

conclusionThis diagnostic signature enables discrimination of HFpEF from non-cardiac dyspnea or HFrEF from EHR and can assist in the diagnostic evaluation in patients with unexplained dyspnea. This approach will enable identification of HFpEF patients who may then benefit from new evidence-based therapies.

Indexed as

Heart FailureDyspneaElectronic Health RecordsHumansPrognosisQuality of LifeRetrospective StudiesStroke VolumeVentricular Function, LeftDyspneaHFpEFMachine learning

Identifiers

PMID36567336
PMCPMC9791783
OpenAlexW4312218422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.